Delphi Genetics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 51

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $50M

Delphi Genetics General Information

Description

Developer of molecular tools designed to offer deoxyribonucleic acid engineering services. The company's tool is used for synthetic biology, allowing successful cloning of genes and expression of recombinant proteins at a higher yield, thereby helping researchers to improve the stability of plasmid DNA in host strains and reproducibility improvement.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Acquirer
Corporate Office
  • Rue A. de Saint-Exupéry, 5
  • 6041 Charleroi
  • Belgium
+32 071 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Delphi Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 25-Feb-2021 $50M 00.000 0000 Completed Generating Revenue
3. Debt - General 28-Jun-2016 00.000 00.000 Completed Generating Revenue
2. Later Stage VC 10-Mar-2015 $1.12M $1.12M Completed Generating Revenue
1. Spin-Off 01-Jan-2001 Completed Startup
To view Delphi Genetics’s complete valuation and funding history, request access »

Delphi Genetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delphi Genetics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Invest4 DelphiG2 Other Minority 000 0000 000000 0
Michel Milinkovitch Angel (individual) Minority 000 0000 000000 0
SambrInvest Venture Capital Minority 000 0000 000000 0
Theodorus Venture Capital Minority 000 0000 000000 0
Université Libre de Bruxelles University Minority 000 0000 000000 0
To view Delphi Genetics’s complete investors history, request access »

Delphi Genetics FAQs

  • When was Delphi Genetics founded?

    Delphi Genetics was founded in 2001.

  • Who is the founder of Delphi Genetics?

    Cedric Szpirer Ph.D is the founder of Delphi Genetics.

  • Where is Delphi Genetics headquartered?

    Delphi Genetics is headquartered in Charleroi, Belgium.

  • What is the size of Delphi Genetics?

    Delphi Genetics has 51 total employees.

  • What industry is Delphi Genetics in?

    Delphi Genetics’s primary industry is Biotechnology.

  • Is Delphi Genetics a private or public company?

    Delphi Genetics is a Private company.

  • What is the current valuation of Delphi Genetics?

    The current valuation of Delphi Genetics is 0000.

  • What is Delphi Genetics’s current revenue?

    The current revenue for Delphi Genetics is 000000.

  • How much funding has Delphi Genetics raised over time?

    Delphi Genetics has raised $4.98M.

  • Who are Delphi Genetics’s investors?

    Invest4 DelphiG2, Michel Milinkovitch, SambrInvest, Theodorus, and Université Libre de Bruxelles have invested in Delphi Genetics.

  • When was Delphi Genetics acquired?

    Delphi Genetics was acquired on 25-Feb-2021.

  • Who acquired Delphi Genetics?

    Delphi Genetics was acquired by Catalent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »